Arcadia Biosciences, Inc. (RKDA) income statement
RKDANasdaqBeveragesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-1.00%)
Close on Nov 18, 2026Market cap $452.45KP/E –Yield –
Arcadia Biosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 34.6%
- Operating margin
- -80.1%
- Net margin
- -234.5%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 3.49
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 253.8%
Valuation
- P/E ratio
- –
- Price to sales
- 0.10
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?